GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Shandong Jincheng Pharmaceutical Group Co Ltd (SZSE:300233) » Definitions » Gross-Profit-to-Asset %

Shandong Jincheng Pharmaceutical Group Co (SZSE:300233) Gross-Profit-to-Asset % : 20.60% (As of Jun. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Shandong Jincheng Pharmaceutical Group Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Shandong Jincheng Pharmaceutical Group Co's annualized Gross Profit for the quarter that ended in Jun. 2024 was ¥1,199 Mil. Shandong Jincheng Pharmaceutical Group Co's average Total Assets over the quarter that ended in Jun. 2024 was ¥5,819 Mil. Therefore, Shandong Jincheng Pharmaceutical Group Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2024 was 20.60%.


Shandong Jincheng Pharmaceutical Group Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Shandong Jincheng Pharmaceutical Group Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Jincheng Pharmaceutical Group Co Gross-Profit-to-Asset % Chart

Shandong Jincheng Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30.05 32.31 31.94 29.19 26.35

Shandong Jincheng Pharmaceutical Group Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.03 23.90 31.00 28.07 20.60

Competitive Comparison of Shandong Jincheng Pharmaceutical Group Co's Gross-Profit-to-Asset %

For the Chemicals subindustry, Shandong Jincheng Pharmaceutical Group Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shandong Jincheng Pharmaceutical Group Co's Gross-Profit-to-Asset % Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Shandong Jincheng Pharmaceutical Group Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Shandong Jincheng Pharmaceutical Group Co's Gross-Profit-to-Asset % falls into.



Shandong Jincheng Pharmaceutical Group Co Gross-Profit-to-Asset % Calculation

Shandong Jincheng Pharmaceutical Group Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=1547.185/( (5826.162+5916.079)/ 2 )
=1547.185/5871.1205
=26.35 %

Shandong Jincheng Pharmaceutical Group Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Jun. 2024 )/( (Total Assets (Q: Mar. 2024 )+Total Assets (Q: Jun. 2024 ))/ count )
=1198.848/( (5900.504+5737.806)/ 2 )
=1198.848/5819.155
=20.60 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Jun. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Shandong Jincheng Pharmaceutical Group Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Shandong Jincheng Pharmaceutical Group Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Shandong Jincheng Pharmaceutical Group Co Business Description

Traded in Other Exchanges
N/A
Address
No. 1 Shuangshan Road, Zichuan Economic Development Zone, Shandong, Zibo, CHN, 255100
Shandong Jincheng Pharmaceutical Group Co Ltd is engaged in the research and development, production and sale of III and IV cephalosporin intermediates and biopharmaceuticals. It offers characteristic bulk drugs, pharmaceutical intermediates, and fine chemicals. The company distributes its products within domestic market and to overseas markets.
Executives
Yang Xiu Liang Executives
Zhang Xue Bo Director
Zheng Geng Xiu Director
Zhao Ye Qing Director
Sun Rui Mei Executives
Cui Xi Li Executives
Zhao Hong Fu Director
Fu Miao Qing Executives
Zhu Xiao Gang Directors, executives
Li Jia Quan Directors, executives
Guo Fang Shui Supervisors
Chou Qiang Securities Affairs Representative

Shandong Jincheng Pharmaceutical Group Co Headlines

No Headlines